Latest News about REGN
Recent news which mentions REGN
Stocks That Hit 52-Week Highs On Wednesday
August 18, 2021
From Benzinga
5 Stocks Insiders Are Selling
August 18, 2021
From Benzinga
From Benzinga
JD.com And Tesla Lead The Nasdaq Lower Tuesday
August 17, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
From Benzinga
From Benzinga
From Motley Fool
Regeneron's Antibody Cocktail Authorized for Preventing COVID: Why It's Not a Big Deal for the Stock
August 14, 2021
Tickers
REGN
From Motley Fool
eBay And AMD Lead The QQQ Friday
August 13, 2021
From Benzinga
What Rinvoq's Positive News Means for AbbVie
August 13, 2021
From Motley Fool
FDA expected to authorize an extra COVID-19 dose for people with weak immune systems in the first regulatory OK for a booster shot in the U.S.
August 12, 2021
From MarketWatch
Will Moderna Buy Editas Medicine to Jump Into Gene Editing?
August 12, 2021
From Motley Fool
From Benzinga
Tickers
REGN
From Motley Fool
Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients
August 05, 2021
From Benzinga
What Will the Stock Market Do Today? 3 Big Stories to Watch.
August 05, 2021
From InvestorPlace
Delta, Lambda Covid Variants Still Weighing On Market Despite Positive Earnings Reports
August 05, 2021
From Benzinga
Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer
August 05, 2021
From Benzinga
Regeneron Beats Street Estimates Big In Q2 As COVID-19 Antibody Boosts Topline, Cuts FY21 R&D Spend Outlook
August 05, 2021
Tickers
REGN
From Benzinga
From Motley Fool
10 Biggest Price Target Changes For Monday
August 02, 2021
From Benzinga
FDA Approves Regeneron - Roche's COVID-19 Antibody Cocktail For Post-Exposure Prophylaxis
August 02, 2021
From Benzinga
Videogames entered the mainstream in the pandemic, but the industry faces a rough transition
August 01, 2021
From MarketWatch
Is a Meltdown on the Way for Moderna Stock?
July 30, 2021
From Motley Fool
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
From Benzinga
Regeneron - Sanofi's Dupixent Improves Itch, Hives In Inflammatory Skin Disease Patients
July 29, 2021
From Benzinga
Is This Mid-Cap Biotech Stock a Buy Now?
July 29, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.